Allegro Ophthalmics scores $10.7 mln

Allegro Ophthalmics LLC, a biotech company focused on treating vitreoretinal diseases, has secured $10.7 million in funding. The investors were not named.

24 July 2017•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail